Since the enactment of the HITECH Act in 2009, taxpayers and the medical industry have collectively invested more than $100 billion in an information technology infrastructure suited to America’s 21st century health needs. These investments hold vast potential for revolutionizing medical science, population health, and cost management. Yet realizing this promise requires progress on a wide range of market, regulatory and legislative obstacles, many of which are relics of a “pre-data” era. Nowhere are the potential opportunity costs greater than in genomic medicine—the mapping and sequencing of genes to discover and create individualized treatments for genetically driven diseases like cancer and diabetes.

On December 11, 2014, Health IT Now and the Center for Data Innovation convened a full-day summit to delve into the rapidly expanding market of data-driven solutions that support genomic research and applications in health care. The goal of the summit is to identify the necessary reforms—both legislative and regulatory—to promote data-driven medicine in ways that meaningfully transform care delivery, improve health outcomes and decrease health spending.